Clinical Trial Update: Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase II clinical trial update evaluating nimotuzumab as part of concurrent chemoradiotherapy for stage IIB-IVA cervical cancer. The spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN